Screener / Neurological Therapies / Biogen Inc

BIIB · NASDAQ

Biogen Inc

Compliant

Under AAOIFI Standard 21, Biogen Inc is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerBIIB
ExchangeNASDAQ
SectorNeurological Therapies

Full ratios for Biogen Inc (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Biogen Inc or any other security.